patent.fyi
Applications  /  US 2026/0354881
United States Patent Application Publication

US 2026/0354881 A1

Published
Nov 12, 2026
Filed
Oct 26, 2023
Earliest date on the face
Oct 28, 2022
Classification
A61B 18/00
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Compact module in a pocket

What ifWhat if a compact electrode module sits in a pocket opened directly over the treatment site?
Claim language“an elongated structure”

A flat ceramic module with two electrode faces is placed directly into a chest-wall pocket through the incision over the target. A pulse generator energizes the two faces through insulated conductors, and the electric field passes through the tissue between them.

1.1Treatment through skin pads

What ifWhat if the pulse delivery hardware stays entirely outside the patient?
Claim language“to an implantation site within the patient”

Two conductive hydrogel pads adhere to intact skin on opposite sides of a superficial chest-wall target. An external pulse generator applies voltage between the pads, and their spacing and contact area shape the field in the skin and underlying tissue.

1.2Electrodes on the proximal shaft

What ifWhat if the electrode pair sits on the proximal shaft while an insulating distal tip extends beyond the target?
Claim language“electrode carried on a distal portion”

A short percutaneous shaft enters through an access point adjacent to the treatment site. Two contact bands on the proximal portion straddle the superficial target, and the pulse generator establishes a local field between the bands.

1.2Electrode clips on exposed tissue

What ifWhat if two standalone electrode clips attach directly to exposed tissue?
Claim language“electrode carried on a distal portion of the elongated structure”

Two spring clips with conductive jaws grip opposite margins of the exposed tissue. Flexible insulated leads connect each clip to a separate generator terminal, and pulses establish a field across the tissue between the clips.

1.3Cooling an intercostal nerve

What ifWhat if a cryoprobe cools the target nerve to reduce sensation?
Claim language“deliver electroporation energy”

A gas-expansion cryoprobe contacts tissue next to the selected intercostal nerve. Cooling forms a local ice zone around the nerve and interrupts conduction through the treated segment.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Electroporation fixture for tissue testing

A transparent benchtop fixture holds an excised chest-wall sample against the inside of a molded ribcage, with a conductive heart-shaped phantom behind the sample. An elongated probe enters through a lateral port and places two distal electrodes against the sample on the anterior side of the phantom. A pulse generator drives the electrodes while a fluorescence camera records uptake of a membrane-impermeant dye in the sample.

Component substitution

Flush platinum foil contact pads

Two platinum foil pads replace the distal electrode bodies and sit flush in recesses on one face of an insulating distal carrier. Insulated conductors run through the elongated shaft, and each conductor terminates at the back of one pad. A radiopaque marker on the opposite face identifies pad orientation under imaging, and the pulse generator applies a voltage between the pads to electroporate chest-wall tissue anterior to the heart.

Parameter or scale variation

Selectable spacing between distal electrodes

Three circular electrodes, each 2 mm in diameter, share a flat distal carrier at 5 mm center-to-center intervals. An internal conductor connects each electrode to a separate terminal on a pulse-rated switching unit. With the electrode face directed toward the ribcage, the switching unit selects either an adjacent pair at 5 mm spacing or the end pair at 10 mm spacing and leaves the third electrode electrically floating during delivery.

Combination with existing systems

Pulse gating with electrocardiogram input

Surface electrodes feed an electrocardiogram monitor whose isolated R-wave trigger output connects to the pulse generator. The elongated shaft positions a distal electrode pair against chest-wall tissue anterior to the heart. Following a delivery command, the generator uses the next accepted trigger to start a pulse burst within a programmed cardiac timing window and suppresses delivery when the monitor reports a signal-quality fault.

Electrode orientation on tracked ultrasound

A miniature electromagnetic tracking sensor sits inside the distal shaft at a fixed position and angle relative to the electrode face. A tracked ultrasound probe images the chest wall and the anterior surface of the heart, and the navigation workstation registers the image and shaft sensor in the same coordinate frame. The workstation overlays the electrode location and facing direction on the ultrasound image so the operator can orient the electrodes toward the chest wall before triggering the pulse generator.

Automated or data-driven variant

Automatic verification of electrode contact

A fiber-optic strain sensor is bonded inside a compliant section of the distal carrier behind the electrode face and connects to an optical reader at the proximal handle. The controller converts the measured wavelength shift to contact force using a calibration curve and measures impedance through the distal electrode pair with a low-amplitude test signal. The generator enables a pulse burst when force and impedance stay within their configured bands for a programmed dwell time, and the controller repeats both checks before each subsequent burst.

Specific version of a part

Guidewire tracked access shaft

A polymer shaft with a braided reinforcement layer and a central lumen tracks over a guidewire from a small incision to the chest-wall implantation site. The guidewire is withdrawn after the shaft reaches the site.

Distal bipolar ring contacts

Two platinum-iridium rings sit in grooves on the distal shaft and are separated by an insulating polymer spacer. An insulated conductor runs from each ring through the shaft lumen to a separate generator terminal.

Directional distal contact pads

Two flush metal pads occupy one face of a flattened distal shaft section. The polymer shaft insulates the rear and edges of each pad, leaving the exposed faces in contact with tissue.

Image guided anterior pulse delivery

Two radiopaque markers identify the axis of a distal electrode pair, and imaging guides rotation toward the rib-adjacent target anterior to the heart. An isolated generator applies biphasic pulses across the contacts, creating an electric field that permeabilizes cell membranes in the intervening tissue.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2022/0096151 A1
Published
Mar 31, 2022
Filed
Sep 28, 2021
Class
A61B 18/1492
Document BUS 2022/0257297 A1
Published
Aug 18, 2022
Filed
Feb 10, 2022
Class
A61B 18/00
Claim 1
Document A
Document B
1.1a medical device comprising: an elongated structure configured to be navigated from an access point of a patient to an implantation site within the patient
In embodiments, the introducer sheath 110 is operable to provide a delivery conduit through which the electroporation catheter 105 may be deployed to the specific target sites within the patient's heart 30.
A · US 2022/0096151 A1 · ¶ 55
In embodiments, the introducer sheath 110 is operable to provide a delivery conduit through which the electroporation catheter 105 may be deployed to the specific target sites within the patient's heart 30.
B · US 2022/0257297 A1 · ¶ 60
1.2at least one electrode carried on a distal portion of the elongated structure
The ablation catheter including a handle, a shaft having a distal end, and catheter electrodes situated at the distal end of the shaft and spatially arranged to generate electric fields in the targeted tissue in response to electrical pulses.
A · US 2022/0096151 A1 · abstract
The ablation catheter including a handle, a shaft having a distal end, and catheter electrodes situated at the distal end of the shaft and spatially arranged to generate electric fields in the targeted tissue in response to electrical pulses.
B · US 2022/0257297 A1 · abstract
1.3wherein the at least one electrode is configured, when proximate to the implantation site, to be oriented relative to a heart of the patient, and wherein the at least one electrode is configured to deliver electroporation energy to electroporate tissue proximate a ribcage of the patient and anterior to the heart.
In embodiments, the electroporation system 60 is configured to deliver electric field energy to targeted tissue in the patient's heart 30 to create tissue apoptosis, rendering the tissue incapable of conducting electrical signals.
A · US 2022/0096151 A1 · ¶ 53
In embodiments, the electroporation system 60 is configured to deliver electric field energy to targeted tissue in the patient's heart 30 to create tissue apoptosis, rendering the tissue incapable of conducting electrical signals, using at least one of the plurality of electrodes 201a, 201b, 201c, 201d, 201e, and 201f of the electroporation electrode arrangement 150 and, in some embodiments, the surface patch electrode 115.
B · US 2022/0257297 A1 · ¶ 83

An empty cell means only that no passage was reproduced there.

Statements in these documents
A way of delivering effective IRE energies while avoiding SMS is needed.
A · US 2022/0096151 A1 · ¶ 6
Wherein the preconditioning pulse sequence includes preconditioning electrical pulses configured to cause electrolysis near the targeted tissue and tetanizing skeletal muscle stimulation in the patient.
A · US 2022/0096151 A1 · ¶ 7
A way of delivering effective IRE energies while avoiding SMS is needed.
B · US 2022/0257297 A1 · ¶ 6
Wherein, the electroporation pulse sequence includes multiple pulse bursts, and each of the multiple pulse bursts includes pulses separated by an inter-pulse length of between 200 and 350 microseconds to reduce muscle stimulation while creating electroporation lesions.
B · US 2022/0257297 A1 · ¶ 7
Cite aspatent.fyi, US 2026/0354881 A1, claim 1, first published 2026-11-19T04:53:05-05:00, https://patent.fyi/US20260354881/, SHA-256 c65439115d8b1953659bd2c1e68cf9349752e8c2e7b15a8a424aff56cc4fbe00
First published
Permanent addresshttps://patent.fyi/US20260354881/
Content fingerprint (SHA-256)c65439115d8b1953659bd2c1e68cf9349752e8c2e7b15a8a424aff56cc4fbe00
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi